| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |